Analyst firms · Citizens JMP · SBRA

Citizens JMP SBRA price target and rating history

Sabra Health Care REIT Inc. (SBRA) · Real Estate

Citizens JMP rates Sabra Health Care REIT Inc. (SBRA) Mkt Outperform with a $20 price target, as of its latest action on Jan 7, 2025. It has published 3 rating actions on SBRA since September 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.

Current rating
Mkt Outperform
Price target
$20
Median target, all firms
$21
Actions on SBRA
3

Citizens JMP price target on SBRA

$22$20$1820222023202420252026
Citizens JMP price target on SBRA, each point a stated target, September 2021 to January 2025.

Every Citizens JMP rating on SBRA

How other firms rate SBRA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
HuntingtonOutperform$23Sep 10, 2026
Raymond JamesMkt PerformAug 6, 2026
Truist SecuritiesHoldJul 8, 2026
BarclaysOverweight$21Jul 7, 2026
CitigroupNeutral$19Jun 23, 2026

Questions about Citizens JMP and SBRA

What is Citizens JMP's price target for SBRA?
Citizens JMP's latest stated price target for Sabra Health Care REIT Inc. (SBRA) is $20, from its action on Jan 7, 2025.
What is Citizens JMP's rating on SBRA?
Citizens JMP rates SBRA Mkt Outperform, a bullish rating, as of Jan 7, 2025.
When did Citizens JMP last change its view on SBRA?
On Jan 7, 2025, Citizens JMP upgrades to Mkt Outperform from Mkt Perform, price target $20.
How does Citizens JMP's SBRA target compare with other analysts?
Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.

More SBRA rating histories

All Citizens JMP ratingsSBRA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.